Form 8-K - Current report:
SEC Accession No. 0001493152-24-048330
Filing Date
2024-12-02
Accepted
2024-12-02 17:27:33
Documents
19
Period of Report
2024-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52072
2 ex10-1.htm EX-10.1 230094
3 ex10-2.htm EX-10.2 132781
4 ex10-3.htm EX-10.3 86479
5 ex10-4.htm EX-10.4 77035
  Complete submission text file 0001493152-24-048330.txt   914638

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE celu-20241125.xsd EX-101.SCH 3892
7 XBRL DEFINITION FILE celu-20241125_def.xml EX-101.DEF 30206
8 XBRL LABEL FILE celu-20241125_lab.xml EX-101.LAB 37063
9 XBRL PRESENTATION FILE celu-20241125_pre.xml EX-101.PRE 27229
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6056
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 241520229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)